Nuvectis Pharma: Funding, Investors & Team (Sep 2026)
Nuvectis Pharma is a biopharmaceutical company focused on creating new targeted treatments for cancer. The company is headed by a team of experienced industry professionals who have successfully developed drugs and navigated clinical and regulatory processes. Through our expertise in selecting targets, profiling drugs, and executing clinical trials, we are working to develop a range of new products for cancer treatment.
Nuvectis Pharma has raised $116M across 2 funding rounds on record, the most recent an undisclosed round of $100M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nuvectis Pharma Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Nuvectis Pharma Funding Rounds
Nuvectis Pharma raised $15.5M in an undisclosed round announced in Feb 2025.
1.3 years later, an undisclosed round of $100M was announced in Jun 2026.
Nuvectis Pharma Founders and Leadership Team
No contact details are on record for this team yet.
Nuvectis Pharma Funding Compared to Other Biotechnology Startups
Nuvectis Pharma's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nuvectis Pharma in Biotechnology and Fort Lee
Companies Similar to Nuvectis Pharma
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Nuvectis Pharma Funding FAQs
What does Nuvectis Pharma do?
Nuvectis Pharma is a biopharmaceutical company focused on creating new targeted treatments for cancer. The company is headed by a team of experienced industry professionals who have successfully developed drugs and navigated clinical and regulatory processes. Through our expertise in selecting targets, profiling drugs, and executing clinical trials, we are working to develop a range of new products for cancer treatment.
How much funding has Nuvectis Pharma raised?
Nuvectis Pharma has raised $116M across 2 rounds on record. The most recent is an undisclosed round of $100M announced in Jun 2026.
When did Nuvectis Pharma last raise funding?
Nuvectis Pharma's most recent funding round on record is an undisclosed round of $100M, announced in Jun 2026.
Who founded Nuvectis Pharma?
FundedIQ lists Ron Bentsur (Founder) at Nuvectis Pharma.
Where is Nuvectis Pharma headquartered?
Nuvectis Pharma is based in Fort Lee, New Jersey, United States.
How many employees does Nuvectis Pharma have?
Nuvectis Pharma is in the 11-50 employee band.
How does Nuvectis Pharma's funding compare to other Biotechnology startups?
Nuvectis Pharma's latest round of $100M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Nuvectis Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nuvectis Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.